UCB's Global Corporate Website

REFERENCES

  1. British Skin Foundation. What is Psoriasis. Available at: https://knowyourskin.britishskinfoundation.org.uk/condition/psoriasis/, Last accessed: August 2022.
  2. Global Psoriasis Atlas. Resources. Available at: https://www.globalpsoriasisatlas.org/resources/resources. Last accessed: August 2022.
  3. Mayo Clinic. Psoriasis: Symptoms & Causes. Available at: https://www.mayoclinic.org/diseases-conditions/psoriasis/symptoms-causes/syc-20355840. Last accessed: August 2022.
  4. Griffiths C, van der Walt J, Ashcroft D, et al. The global state of psoriasis disease epidemiology: a workshop report. Br J Dermatol. 2017;177(1):e4–e7.
  5. Møller A, Erntoft S, Vinding G, et al. A systematic literature review to compare quality of life in psoriasis with other chronic diseases using EQ-5D-derived utility values. Patient Relat Outcome Meas. 2015;6:167-177.
  6. NPF. Related Conditions of Psoriasis. Available at: https://www.psoriasis.org/related-conditions/. Last accessed: August 2021.
  7. Reddy M, Chaturvedi S. Psychosocial issues in dermatology. EMJ Dermatol. 2017;5(1):83-89.
  8. Augustin M, Sommer R, Kirsten N, et al. Topology of psoriasis in routine care: results from high-resolution analysis of 2009 patients. Br J Dermatol. 2019;181(2):358-365.
  9. Alpsoy E, Polat M, FettahlıoGlu-Karaman B, et al. Internalized stigma in psoriasis: a multicenter study. J Dermatol. 2017;44(8):885-891.
  10. Sampogna F, Linder D, Piaserico S, et al. Quality of life assessment of patients with scalp dermatitis using the Italian version of the Scalpdex. Acta Derm Venereol. 2014;94(4):411-414.
  11. Hrehorów E, Salomon J, Matusiak L, et al. Patients with psoriasis feel stigmatized. Acta Derm Venereol. 2012;92:67-72.
  12. Sampogna F, Tabolli S, Abeni D, et al. Living with psoriasis: prevalence of shame, anger, worry, and problems in daily activities and social life. Acta Derm Venereol. 2012;92:299-303.
  13. Moon HS, Mizara A, McBride SR. Psoriasis and psycho-dermatology. Dermatol Ther (Heidelb). 2013;3(2):117-130.
  14. Gupta MA, Simpson FC, Gupta AK. Psoriasis and sleep disorders: A systematic review. Sleep Med Rev. 2016;29:63-75. doi: 10.1016/j.smrv.2015.09.003.
  15. Krueger G, Koo J, Lebwohl M, et al. The Impact of Psoriasis on Quality of Life: Results of a 1998 National Psoriasis Foundation Patient-Membership Survey. Arch Dermatol. 2001;137(3):280-4.
  16. World Health Organization. Global Report on Psoriasis 2016. Available at: https://apps.who.int/iris/bitstream/handle/10665/204417/9789241565189eng.pdf.psoriasis?sequence=1. Last accessed: August 2022.
  17. National Psoriasis Foundation. Locations and Types. Available at: https://www.psoriasis.org/locations-and-types/. Last accessed: August 2022.
  18. NHS UK. Psoriasis Causes. Available at: https://www.nhs.uk/conditions/psoriasis/causes. Last accessed: August 2022.
  19. Lee EB, Wu KK, Lee MP, et al. Psoriasis Risk Factors and Triggers. Cutis. 2018;102(5S):18-20.
  20. Rendon A, Schäkel K. Psoriasis Pathogenesis and Treatment. Int J Mol Sci. 2019;20(6):1475.
  21. Lebwohl MG, Kavanaugh A, Armstrong AW, et al. US Perspectives in the Management of Psoriasis and Psoriatic Arthritis: Patient and Physician Results from the Population-Based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) Survey. Am J Clin Dermatol. 2016; 17(1):87-97.
  22. Armstrong AW, Read C. Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review. JAMA 2020;323(19):1945-1960.

© 2007 - 2024 UCB S.A., Belgium. All rights reserved. Last updated on: March, 11, 2024